Hutch News
Results per Page:
Untangling how body location promotes cancer
Beronja Lab postdoc Rachel Lex receives ACS fellowship to uncover regional factors driving tumor development
How cancer doesn't happen - Part 2
Our bodies can keep tumors at bay, even if our cells harbor cancer-driving mutations
Rethinking why cancer doesn't happen - Part 1
Hutch scientists look beyond DNA to understand how our bodies stop tumors before they start and find new ways prevent cancer
Tip Sheet: Disparities in cancer outcomes, catching up on cancer screenings, boosting immunotherapy effectiveness and SARS-CoV-2 origins
Summaries of recent Fred Hutch research findings and other news
Mutated skin stem cells self-correct to prevent cancer
New study helps explain why inherited cancer-driving mutations don’t always lead to cancer
New nanoparticles make targeted, temporary gene therapy possible
‘Hit-and-run’ technology could improve immunotherapy and HIV cure research
Stem cells from bone marrow may be better than blood when it comes to quality of life for transplant patients, study suggests
New study explores whether stem cells from bone marrow or blood offer transplant patients better quality of life
Good News at Fred Hutch
Public health researchers get $4 million grant to study aggressive type of colorectal cancer; Core Center of Hematology designated as national core resource
Enterovirus D68 seen in cancer, stem cell transplant patients
Virus behind outbreak that sickened children also caused illness in immunocompromised adults
Beyond blood drives: Stem cell donors help fuel scientific discovery
Volunteers for the little-known procedures earn up to $800 – and the chance to contribute to cutting-edge research
Gene therapy boosts chemotherapy tolerance and effectiveness of medications that attack brain cancer
Stem-cell protocol could be used with other malignant solid tumors
Appelbaum editorial: Evidence tips transplant practice back to bone marrow
In New England Journal of Medicine editorial, Fred Hutchinson Cancer Research Center’s Dr. Fred Appelbaum argues adult stem cells harvested from bone marrow rather than blood of unrelated donors are best for reducing graft-vs.-host disease risk
Watts' cord blood research garners award
Kiem Lab's Korashon Watts explores cord blood stem cell expansion; lauded by American Society of Gene & Cell Therapy
Bradley, Skene win Damon Runyon awards
Robert Bradley's $100,000 continuation award supports alternative RNA splicing research; Peter Skene's $156,000 grant aids cellular reprogramming efforts
Modified marrow cells may resist chemotherapy’s toxic effects
Hans-Peter Kiem and colleagues find chemo-resistant genes may enable safer, more effective treatment for brain cancer patients